Tarang Sharma and colleagues argue for increased collaboration across public and private sectors—internationally and with patients—in drug assessment and managed entry agreements to support equitable ...

Discover why IPO Genie is among the top growing presales of 2025. Learn how its AI-driven access and real utility are ...

Zydus Lifesciences secures first China approval for antidepressant Venlafaxine ER, marking its entry into the market and expanding its global footprint.

Electro Optic Systems Holdings Limited is attractive after a sharp pullback, offers compelling entry point amid strong demand ...

KLIA embraces digital transformation with Vehicle Access Management System to make airport traffic faster, safer and more ...

After bursting onto the scene with a fresh narrative, DeepSnitch AI’s early momentum seems to have cooled even as the broader market recovers. Bitcoin, on the o ...

BullZilla ($BZIL) continues to dominate presale discussions, setting the gold standard for disciplined tokenomics, ...

Utilizing the Health Insurance Disparities Index for assessment, the authors found that New York’s Medicaid health maintenance organizations (HMOs) outperformed Medicaid HMOs nationally in addressing ...

Zoltán Kaló and colleagues consider approaches to counter systemic inequities and power imbalances arising from discrete national policies for drug pricing and reimbursement Current pricing mechanisms ...